Track topics on Twitter Track topics that are important to you
Innate Pharma has preliminary Phase I data showing its monoclonal antibody could treat colorectal cancer that is unresponsive to PD-1/L1 checkpoint inhibitors. French biotech Innate Pharma has obtained promising Phase I data for its monoclonal antibody monalizumab in treating colorectal cancer. ...
This awesome article This Antibody Could Boost Checkpoint Inhibitors in Treating Colorectal Cancer appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)NEXT ARTICLE
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...
Astroesophageal Reflux Disease (GERD) Barrett's Esophagus Celiac Disease Cholesterol Crohn's Disease Gastroenterology Hepatitis Hepatology Irritable Bowel Syndrome (IBS) Pancreatitis Peptic Ulcer Disease...